Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri®) in inflammatory diseases

Olaf Stüve, Jeffrey L. Bennett

Research output: Contribution to journalReview articlepeer-review

99 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri®) in inflammatory diseases'. Together they form a unique fingerprint.

Medicine & Life Sciences